论文部分内容阅读
近年来人们对肺癌发生的分子生物学机制有了深入了解 ,并力图从分子水平寻找新的治疗靶点。与细胞生存密切相关的端粒酶作为肿瘤细胞的标志物之一 ,有可能成为诊断或治疗的靶位点。本文通过测定手术后肺癌组织和癌旁肺组织的端粒酶ｍＲＮＡ表达 ,研究其与肺癌ＴＮＭ分期的关系[
In recent years, people have gained an in-depth understanding of the molecular biology mechanisms of lung cancer and sought to find new therapeutic targets at the molecular level. Telomerase, which is closely related to cell survival, is one of the markers of tumor cells and may become a diagnostic or therapeutic target site. In this paper, the relationship between the expression of telomerase mRNA and the TNM staging of lung cancer was studied by measuring the expression of telomerase mRNA in lung cancer tissue and adjacent lung tissue after surgery.